Good Therapeutics

Seattle

Good Therapeutics is a biopharmaceutical organization involved in drug development, with notable activities related to acquiring and advancing therapeutic drug programs.

Facts

HQ
Seattle
Sectors
Biotechnology, Biopharmaceuticals, Immuno-oncology, Drug development
Stage
Series A
Members see funding amounts.
.

Is this your organization? Claim it

Bonum Therapeutics Moves to New Seattle Offices, Plans Team Expansion in Cancer Immunotherapy Push

Seattle biotech startup Bonum Therapeutics is relocating to a new office at 1150 Eastlake Ave E and plans to double its 31-person team as it pursues developing safer immunotherapy cancer drugs. Founded by CEO John Mulligan after a $250 million acquisition of his previous company Good Therapeutics by Roche, Bonum recently raised $93 million to fund its expansion.

See all 5 stories, episodes and videos about Good Therapeutics.

Online